WHO ICTRP trial
The randomized controlled trial of the R-THP-COP therapy (14 days) versus R-CHOP…
JPRN-UMIN000007283 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000007283 |
|---|---|
| Public title | The randomized controlled trial of the R-THP-COP therapy (14 days) versus R-CHOP therapy (14 days) for treatment of patients under the age of 70 with untreated advanced stage diffuse large B-cell lymphoma, Phase II and III study |
| Scientific title | The randomized controlled trial of the R-THP-COP therapy (14 days) versus R-CHOP therapy (14 days) for treatment of patients under the age of 70 with untreated advanced stage diffuse large B-cell lymphoma, Phase II and III study - The randomized controlled trial of the R-THP-COP therapy (14 days)… |
| Primary sponsor | Gifu University Hospital |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase II,III |
| Countries | Japan |
| Conditions | diffuse large B-cell lymphoma |
| Interventions | R-THP-COP therapy (14 days) R-CHOP therapy (14 days) |
| Registration date | Feb 13, 2012 |
| Target size | 80 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: